Cargando…
Rapamycin as a potent and selective inhibitor of vascular endothelial growth factor receptor in breast carcinoma
Angiogenesis is the process of new vascular formation, which is derived from various factors. For suppressing cancer cell growth, targeting angiogenesis is one of the therapeutic approaches. Vascular endothelial growth factor family receptors, including Flt-1, Flk-1 and Flt-4, have been found to pla...
Autores principales: | Muhammad Sakri, Muhammad Shahidan, Tengku Din, Tengku Ahmad Damitri Al-Astani, Jaafar, Hasnan, Gopalan, Vinod, Wan Abdul Rahman, Wan Faiziah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777331/ https://www.ncbi.nlm.nih.gov/pubmed/35037503 http://dx.doi.org/10.1177/20587384211059673 |
Ejemplares similares
-
Evaluation of NMU-Induced Breast Cancer Treated with Sirolimus and Sunitinib on Breast Cancer Growth
por: Jaffar, Nurul Fathiyatul Nabila, et al.
Publicado: (2020) -
The Unique Biology behind the Early Onset of Breast Cancer
por: Siddig, Alaa, et al.
Publicado: (2021) -
Comparing the Biology of Young versus Old Age Estrogen-Receptor-Positive Breast Cancer through Gene and Protein Expression Analyses
por: Siddig, Alaa, et al.
Publicado: (2023) -
Triple Negative Breast Cancer: A Review of Present and Future Diagnostic Modalities
por: Dass, Sylvia Annabel, et al.
Publicado: (2021) -
The Effects of Tamoxifen on Tolerogenic Cells in Cancer
por: Mohd Idris, Ros Akmal, et al.
Publicado: (2022)